CERS vs IDXX · rev $111.1M vs P/E 40, rev $2.36B
Cerus Corporation (CERS) versus IDEXX Laboratories Inc (IDXX) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
IDEXX Laboratories Inc (IDXX) is a diagnostics & research company listed on NASDAQ.
Latest reported CERS revenue for 2026-06-30 was $111.1M. Net income was -$4.6M. CERS currently screens at market cap $294.4M.
Latest reported IDXX revenue for 2026-06-30 was $2.36B. Net income was $616.9M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
CERS currently screens at market cap $294.4M. IDXX currently screens at market cap $43.08B and trailing P/E 40.2.
Not investment advice. Open the CERS and IDXX stock pages for the full models.
Not investment advice.